Objective: Our aim was to review the safety of percutaneous injection laryngoplasty using bovine crosslinked collagen, focusing specifically on two often-stated concerns: injecting patients who are taking the anticoagulant medication warfarin, and injecting patients without prior skin hypersensitivity testing.
Study Design And Setting: Retrospective chart review of injection laryngoplasty performed between 1997 and 2006 at the University of California, Los Angeles.
Results: The study group consisted of 895 patients who underwent 1290 injection laryngoplasty procedures. No bleeding complications were noted in 59 patients taking warfarin. No allergic complications were reported in 845 patients who did not undergo skin hypersensitivity testing before injection laryngoplasty.
Conclusion: Percutaneous bovine crosslinked collagen injection laryngoplasty is safe in patients taking warfarin. Skin testing for hypersensitivity does not appear to be necessary before injection.
Significance: Patients on warfarin are candidates for injection laryngoplasty without the need to discontinue the medication. Eliminating skin hypersensitivity testing before percutaneous bovine crosslinked collagen injection laryngoplasty allows for a prompt treatment of glottic insufficiency.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.otohns.2006.11.032 | DOI Listing |
J Voice
January 2025
Department of Otolaryngology - Head and Neck Surgery, Thomas Jefferson University Hospital, Philadelphia, PA.
Objectives: Injection laryngoplasty (IL) is commonly performed for glottic insufficiency and has historically been performed under general anesthesia via direct laryngoscopy (DL), with an increasing number of procedures being performed in the office setting via flexible laryngoscopy (FL). Existing literature regarding complications of IL primarily addresses immediate peri-procedural complications and adverse reactions to the injection material. This is the first study utilizing a large multi-institutional database comparing complications of IL performed via DL versus FL.
View Article and Find Full Text PDFLaryngoscope
December 2024
Division of Otolaryngology - Head and Neck Surgery, Phoenix Children's Hospital, Phoenix, Arizona, U.S.A.
Objectives: To investigate the relationship between social determinants of health and timeliness of management, adherence to follow-up, and outcomes of treatment with interarytenoid injection augmentation (IAIA).
Methods: Retrospective cohort study of all pediatric patients treated with IAIA at a large pediatric institution's multidisciplinary aerodigestive clinic between August 2022 and February 2024. Retrieved demographic factors, dates of referral, consultation, treatment, and follow-up, as well as objective measures of dysphagia and aspiration via videofluoroscopic swallow study (VFSS) reports, using dysphagia outcome and severity scale (DOSS) scores and the greatest unsafe thickness, or 'aspiration score'.
Otolaryngol Head Neck Surg
November 2024
Division of Otolaryngology-Head and Neck Surgery, Phoenix Children's Hospital, Phoenix, Arizona, USA.
Objective: The objective of this study was to assess the efficacy and complication rates of interarytenoid injection augmentation (IAIA) for the treatment of dysphagia in patients 1 year of age and under and to determine if concurrent feeding therapy (FT) affects outcome.
Study Design: Retrospective case series.
Setting: Tertiary pediatric hospital.
Indian J Otolaryngol Head Neck Surg
December 2024
Otorhinolaryngology Department, Faculty of Medicine, Tanta University, Tanta, Egypt.
Background: Unilateral vocal fold paralysis (UVFP) is a common condition that may have varying economical and personal consequences for those afflicted by it. Patients often have dysphonia as a primary concern and may also experience aspiration in certain cases. This research aimed to assess the voice and swallowing results after injection laryngoplasty and medialization thyroplasty in patients with UVFP.
View Article and Find Full Text PDFJ Voice
October 2024
Department of Communication Disorders, Sacred Heart University, Fairfield, Connecticut. Electronic address:
Objectives/hypothesis: Vocal impairments are early and debilitating symptoms of Parkinson's disease (PD). Glottal insufficiency is a contributor to PD-related dysphonia. Vocal fold injection laryngoplasty (IL) and medialization thyroplasty (MT) are well-established techniques used to restore glottal closure for a range of causes.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!